SHANGHAI MABGEEK BIOTECH.CO.,LTD.

Room 304, No. 1011 Halei Road, Zhangjiang Hi-tech Park, Shanghai, China

Clinical Trials

8 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Phase 3

40.0%

Phase 2

33.3%

Phase 1

20.0%

Not Applicable

6.7%

Trial Status Distribution

Active, not recruiting

26.7%

Completed

6.7%

Not yet recruiting

26.7%

Recruiting

40.0%

Clinical Trials

Trials sponsored by this organization (15)

A Phase 2 Study of MG-K10 in Chronic Spontaneous Urticaria

Phase 2

Not yet recruiting

interventional

Sep 202660 participants

A Study to Evaluate the Efficacy and Safety of MG-K10 in Participants Who Have Atopic Dermatitis

Phase 3

Not yet recruiting

interventional

May 2026498 participants

A Phase III Study of MG-K10 in Adolescents With Moderate-to-Severe Atopic Dermatitis

Phase 3

Not yet recruiting

interventional

Apr 2026180 participants

A Study of MG-K10 in Chronic Spontaneous Urticaria

Phase 3

Not yet recruiting

interventional

Apr 2026226 participants

A Study of MG-K10 Humanized Monoclonal Antibody Injection in Subjects With Atopic Dermatitis

Phase 2

Completed

interventional

Jun 202560 participants

Study of MG-ZG122 Humanized Monoclonal Antibody in Asthma Subjects

Phase 2

Active, not recruiting

interventional

May 2025160 participants

Clinical Trial of MG-K10 in Stage III of Moderate to Severe Asthma

Phase 3

Recruiting

interventional

Mar 2025504 participants

Phase II/III Seamless Clinical Study of MG-K10 Humanized Monoclonal Antibody Injection in Treatment of Seasonal Allergic Rhinitis

Phase 2

Recruiting

interventional

Mar 2025160 participants

Page 1 of 2

Approvals

No approval data available

News

No news articles found

Back to Organizations